Liang Zhang

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Live Nation Entertainment, Inc. of an aggregate…

Davis Polk advised the joint book-running managers in connection with the $80 million public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on the NASDAQ…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $500 million aggregate principal amount of 4.600% senior notes due 2028…

Davis Polk advised Natura Cosméticos S.A. in connection with its $750 million offering of 5.375% senior notes due 2023, which were issued pursuant to Rule 144A and Regulation S under the…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Nutanix, Inc. of $575 million aggregate principal amount of its 0% convertible…

Davis Polk advised Toyota Motor Credit Corporation in connection with an SEC-registered offering of $750 million aggregate principal amount of 2.200% medium-term notes, Series B due 2020, …

Davis Polk advised the joint bookrunners in connection with the secondary, follow-on offering by the selling shareholders of a total of 18,846,177 units of Companhia de Saneamento do…

Davis Polk advised Morgan Stanley on the recommencement of its SEC-registered financing programs and the related filing of its universal shelf registration statement, which includes a…

Davis Polk advised Vinci Shopping Centers Fundo de Investimento Imobiliário – FII in connection with a global offering of 2,302,555 quotas of Vinci’s capital stock consisting of a public…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering of $325 million aggregate principal amount of 5.50% senior notes…